Skip to main content
. 2017 Apr 4;7:623. doi: 10.1038/s41598-017-00755-y

Figure 4.

Figure 4

Long-term follow-up of newly diagnosed patients. Two CML patients were followed from the time of initial diagnosis, by measuring BCR-ABL1 positive cells using PLA-flow and BCR-ABL1 transcript levels using RQ-PCR, every 3 months over a period of 9 months. (A and B) Display results for patient 1 and 2, respectively, analyzed with PLA-flow (diamonds) and RQ-PCR (circles).